A priority review in Stargardt disease, two pivotal-trial milestones, an emerging bispecific for wet AMD, and new diagnostic ...

Antibiotic injection reduced endophthalmitis risk vs topical drops after cataract surgery, meta-analysis found.

The status of the choriocapillaris may be a valuable factor when monitoring the macular microvasculature in prediabetes and ...

Jonathan Gloth, MD, discusses how a dual Tie2/VEGF mechanism could reduce injection burden and the consequences of missed ...

John W. Kitchens, MD, discusses patient selection for geographic atrophy treatment, counseling approaches, and emerging ...

Two optical treatment modalities have accumulated the strongest evidence base for slowing pediatric myopia progression ...

Zhang traced growing interest in home tonometry back to the COVID-19 pandemic, when clinicians needed new ways to track patie ...

Angela Y. Zhu, MD, of Bascom Palmer Eye Institute, explains how to distinguish eye allergy from vision-threatening VKC and AKC in children and when steroid-sparing therapy and referral are warranted.

The FDA has granted Avulux De Novo marketing authorization for its precision optical filter lens, creating the first FDA-recognized device classification for a lens targeting migraine-associated ...

Japan's Ministry of Health, Labour and Welfare (MHLW) granted orphan drug designation to gildeuretinol acetate (ALK-001; Alkeus Pharmaceuticals) for Stargardt disease, a status that unlocks ...

A peer-reviewed study evaluating serial application of decellularized basement membrane (DBM) (Biovance Ocular; DefEYE) in patients with subclinical or Mackie Stage 1 neurotrophic keratitis (NK) found ...

Artelo Biosciences has enrolled the first patient in the phase 2 DREAM study, evaluating the company’s orally administered synthetic cannabinoid, ART27.13, in patients with glaucoma or ocular ...